[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF 20-30 AND 136-150, VARIANT THR-357, FUNCTION, INTERACTION WITH U1 SNRNA, AND RNA-BINDING.
TISSUE=Bone, and Cervix carcinoma;
PubMed=8752089 [NCBI, ExPASy, EBI, Israel, Japan]
Arning S.,
Grueter P.,
Bilbe G.,
Kraemer A.;
"Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA.";
RNA 2:794-810(1996).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 6).
TISSUE=Myeloid leukemia cell;
DOI=10.1006/geno.1997.4705; PubMed=9192847 [NCBI, ExPASy, EBI, Israel, Japan]
Caslini C.,
Spinelli O.,
Cazzaniga G.,
Golay J.,
De Gioia L.,
Pedretti A.,
Breviario F.,
Amaru R.,
Barbui T.,
Biondi A.,
Introna M.,
Rambaldi A.;
"Identification of two novel isoforms of the ZNF162 gene: a growing family of signal transduction and activator of RNA proteins.";
Genomics 42:268-277(1997).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), AND TISSUE SPECIFICITY.
TISSUE=Brain cortex, Cerebellum, and Fetal liver;
DOI=10.1093/hmg/3.3.465; PubMed=7912130 [NCBI, ExPASy, EBI, Israel, Japan]
Toda T.,
Iida A.,
Miwa T.,
Nakamura Y.,
Imai T.;
"Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1).";
Hum. Mol. Genet. 3:465-470(1994).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4 AND 5).
TISSUE=Brain, Eye, Kidney, Muscle, and Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-295.
DOI=10.1016/S0378-1119(98)00058-4; PubMed=9573336 [NCBI, ExPASy, EBI, Israel, Japan]
Kraemer A.,
Quentin M.,
Mulhauser F.;
"Diverse modes of alternative splicing of human splicing factor SF1 deduced from the exon-intron structure of the gene.";
Gene 211:29-37(1998).
|
[6]
|
PROTEIN SEQUENCE OF 2-15, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND MASS SPECTROMETRY.
TISSUE=T-cell;
Bienvenut W.V.,
Kanor S.,
Tissot J.-D.,
Quadroni M.;
Submitted (MAY-2006) to UniProtKB.
|
[7]
|
PROTEIN SEQUENCE OF 19-28; 94-103; 228-239 AND 298-308, FUNCTION, INTERACTION WITH U2AF2, MUTAGENESIS OF SER-20, AND PHOSPHORYLATION AT SER-20.
DOI=10.1093/emboj/18.16.4549; PubMed=10449420 [NCBI, ExPASy, EBI, Israel, Japan]
Wang X.,
Bruderer S.,
Rafi Z.,
Xue J.,
Milburn P.J.,
Kraemer A.,
Robinson P.J.;
"Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependent protein kinase regulates spliceosome assembly.";
EMBO J. 18:4549-4559(1999).
|
[8]
|
PROTEIN SEQUENCE OF 110-135, MASS SPECTROMETRY, AND INTERACTION WITH THE SPLICEOSOME.
DOI=10.1101/gr.473902; PubMed=12176931 [NCBI, ExPASy, EBI, Israel, Japan]
Rappsilber J.,
Ryder U.,
Lamond A.I.,
Mann M.;
"Large-scale proteomic analysis of the human spliceosome.";
Genome Res. 12:1231-1245(2002).
|
[9]
|
FUNCTION, AND INTERACTION WITH EWSR1; FUS AND TAF15.
DOI=10.1074/jbc.273.29.18086; PubMed=9660765 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang D.,
Paley A.J.,
Childs G.;
"The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription.";
J. Biol. Chem. 273:18086-18091(1998).
|
[10]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0404720101; PubMed=15302935 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Jedrychowski M.,
Schwartz D.,
Elias J.E.,
Villen J.,
Li J.,
Cohn M.A.,
Cantley L.C.,
Gygi S.P.;
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[12]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1038/nbt1240; PubMed=16964243 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Villen J.,
Gerber S.A.,
Rush J.,
Gygi S.P.;
"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.";
Nat. Biotechnol. 24:1285-1292(2006).
|
[13]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASS SPECTROMETRY.
DOI=10.1002/elps.200600782; PubMed=17487921 [NCBI, ExPASy, EBI, Israel, Japan]
Giorgianni F.,
Zhao Y.,
Desiderio D.M.,
Beranova-Giorgianni S.;
"Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line.";
Electrophoresis 28:2027-2034(2007).
|
[14]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-80; SER-82 AND TYR-87, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0611217104; PubMed=17287340 [NCBI, ExPASy, EBI, Israel, Japan]
Molina H.,
Horn D.M.,
Tang N.,
Mathivanan S.,
Pandey A.;
"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.";
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
|
[15]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463 (ISOFORM 6), AND MASS SPECTROMETRY.
DOI=10.1021/pr0705441; PubMed=18220336 [NCBI, ExPASy, EBI, Israel, Japan]
Cantin G.T.,
Yi W.,
Lu B.,
Park S.K.,
Xu T.,
Lee J.-D.,
Yates J.R. III;
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.";
J. Proteome Res. 7:1346-1351(2008).
|
[16]
|
STRUCTURE BY NMR OF 133-255 IN COMPLEX WITH THE BRANCH SITE SEQUENCE 5'-UAUACUAACAA-3', AND MUTAGENESIS OF ASN-151; ARG-160; LYS-184; LEU-244; LEU-247; LEU-254 AND ARG-255.
DOI=10.1126/science.1064719; PubMed=11691992 [NCBI, ExPASy, EBI, Israel, Japan]
Liu Z.,
Luyten I.,
Bottomley M.J.,
Messias A.C.,
Houngninou-Molango S.,
Sprangers R.,
Zanier K.,
Kraemer A.,
Sattler M.;
"Structural basis for recognition of the intron branch site RNA by splicing factor 1.";
Science 294:1098-1102(2001).
|
[17]
|
STRUCTURE BY NMR OF 13-25 IN COMPLEX WITH U2AF2, AND MUTAGENESIS OF 16-LYS--ARG-18; 17-LYS-LYS-18; ARG-21 AND TRP-22.
DOI=10.1016/S1097-2765(03)00115-1; PubMed=12718882 [NCBI, ExPASy, EBI, Israel, Japan]
Selenko P.,
Gregorovic G.,
Sprangers R.,
Stier G.,
Rhani Z.,
Kraemer A.,
Sattler M.;
"Structural basis for the molecular recognition between human splicing factors U2AF65 and SF1/mBBP.";
Mol. Cell 11:965-976(2003).
|
|
ExPASy Home page
SIB Switzerland
